diagnosis

It’s all coming back to Celine Dion.

The French Canadian singer may be making her return to concert performances this fall, according to Variety. In 2022, Dion canceled her North American tour due to muscle spasms and later revealed that her diagnosis with stiff-person syndrome, an autoimmune neurological disorder, would prevent her from performing.

Montreal newspaper La Presse reported that fans were speculating Dion would return to the stage, after Parisians spotted posters referencing titles of Dion’s songs like “Power of Love” and “Pour Que tu M’aimes Encore” throughout the city. La Presse also reported that Dion will likely perform two concerts a week throughout September and October at the Paris La Défense Arena, a venue that seats 40,000 spectators.

Dion has not headlined her own show since her Courage World Tour in 2020, which was postponed and then canceled due to her health issues. She sang an emotional cover of Édith Piaf’s “Hymne à l’amour” during the closing ceremony of the 2024 Olympics. Last November, she performed her songs “I’m Alive” and “The Power of Love” during the 1001 Seasons of Elie Saab fashion show in Riyadh, Saudi Arabia.

The singer publicized her battle with SPS in her 2024 documentary, “I Am: Celine Dion.” In the film, Dion discussed how she’d been experiencing health issues for 17 years before her diagnosis. SPS affected Dion’s ability to sing by causing a strain on her vocal cords, making her voice sound more nasal.

“Sometimes I would point my microphone towards the audience and I would make them sing it. There’s moments where I cheated and I tapped on the microphone, like it was the microphone’s fault,” Dion explained in her documentary.

Even with her diagnosis, the singer made it clear in her documentary that she intended to continue pursuing her love of music.

“If I can’t run, I’ll walk. If I can’t walk, I’ll crawl, but I won’t stop.”

Dion’s representatives did not immediately respond to a request for comment. La Défense Arena declined to comment.

JESY Nelson has shared an adorable video of her daughter’s “ballerina” leg exercises amid her twins’ SMA diagnosis.

The singer gave birth to her little girls prematurely at 31 weeks last year.

And, back in January, Jesy bravely revealed the twins, Ocean Jade and Story Monroe, have since been diagnosed with Spinal Muscular Atrophy Type 1 (SMA1).

It is a genetic condition that weakens the muscles by damaging motor nerve cells in the spinal cord.

It leads to progressive muscle wasting, and if untreated, the life expectancy of a baby with SMA Type 1 is just two years.

Jesy and her ex-fiancee Zion Foster have been told it is unlikely the girls will ever walk, and may face serious breathing and swallowing difficulties.

N-WORD SHAME

Little Mix’s Jesy Nelson slammed for racial slur video at New Year’s Eve party

BAND OF THREE

Jade Thirlwall drops biggest hint yet that full Little Mix reunion is OFF

The brave mum-of-two has been keeping her fans updated on the twins condition on social media.

Jesy, 34, has now shared a sweet clip of the twins doing their “ballerina” exercises to keep their legs mobile.

Speaking to one of the twins in the video, she said: “Are you gonna show them how you move your legs? Your a little ballerina, come on.

“Good girl. Little ballerina, yes you are.”

Progressive resistance training (PRT) with a little resistance band has the potential to increase strength and increase motor function in children and young adults with SMA, according to the National Institute of Health.

Jesy panned the camera up to her daughter’s face and she seemed super chilled as she bent and unbent her leg.

The tot was spotted with her feeding tube in her nose as it helps to clear their chests.

The former Little Mix singer recently released a fly-on-the-wall Amazon Prime documentary.

The series, which climbed to number one in Amazon’s viewing charts, follows her shock departure from Little Mix in 2020 and her journey to motherhood with her now ex-boyfriend Zion.

Since revealing her twins’ diagnosis, Jesy is now campaigning for the NHS to expand the standard heel prick test to screen for SMA1.

She says the test, which costs around £1, could have “saved their legs” by giving them access to treatment sooner.

If the twins had been tested and treated in time, there was a chance they would have avoided disability.